Cargando…
Caffeine for the Pharmacological Treatment of Apnea of Prematurity in the NICU: Dose Selection Conundrum, Therapeutic Drug Monitoring and Genetic Factors
Caffeine citrate is the drug of choice for the pharmacological treatment of apnea of prematurity. Factors such as maturity and genetic variation contribute to the interindividual variability in the clinical response to caffeine therapy in preterm infants, making the optimal dose administered controv...
Autores principales: | Long, Jia-Yi, Guo, Hong-Li, He, Xin, Hu, Ya-Hui, Xia, Ying, Cheng, Rui, Ding, Xuan-Sheng, Chen, Feng, Xu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350115/ https://www.ncbi.nlm.nih.gov/pubmed/34381359 http://dx.doi.org/10.3389/fphar.2021.681842 |
Ejemplares similares
-
Caffeine Therapy for Apnea of Prematurity: Role of the Circadian CLOCK Gene Polymorphism
por: Guo, Hong-Li, et al.
Publicado: (2022) -
Precision caffeine therapy for apnea of prematurity and circadian rhythms: New possibilities open up
por: Dai, Hao-Ran, et al.
Publicado: (2022) -
Comparison of Caffeine versus Theophylline for apnea of prematurity
por: Zulqarnain, Arif, et al.
Publicado: (2019) -
Caffeine in liver diseases: Pharmacology and toxicology
por: Shan, Liang, et al.
Publicado: (2022) -
Caffeine for apnea of prematurity and brain development at 11 years of age
por: Kelly, Claire E., et al.
Publicado: (2018)